Updated 02:03 GMT, 8 Nov 2026 SPX 7,376.86 +0.31% NDX 26,989.99 +1.35% VIX 25.64 -9.01% GOLD 4,074.90 -0.94% CL 90.83 +0.34% BTC 75,624.49 -0.16%
NAS100 26,990 +1.35% S&P 7,377 +0.31% GOLD $4,075 −0.94% BTC $75,624 −0.16% VIX 25.64 −9.01% latest tape · as of 02:03 UTC
The Screen · Financials · Banks - Regional

Webster Financial Corp logoWebster Financial Corp

WBS · the NYSE · USD · Market cap $12.6B · 4,498 employees

Webster Financial Corporation operates as the bank holding company for Webster Bank, National Association that provides various financial products and services to businesses, individuals, and families in the United States.

FAIL · Does not pass the screen
77.57 USD

Price as of 30 Oct 2026Daily close, not a live quoteLast reviewed 9 days ago

Screened 2026-10-30 · the tape above runs as of 02:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price77.57 USD at the 30 Oct 2026 close
  • Our value readFair vs our fair value, as of 30 Oct 2026
  • Our regime readAccumulation, as of 1 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed30 Oct 2026 (9 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $79.35 to $132.24, base estimate $81.00 (screen dated 2026-10-30).

Current read
Accumulation ?
Fair · screened 2026-10-30
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price77.57 USD
Fair value81.00
Ethical score30.0/100
Value readFairas of 30 Oct 2026
Our investment reviews on this name
2026-07-02Read Accumulation73.91+5.0% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Webster Financial Corp holds its Accumulation at $77.57. The statistical read favours the sellers, held for 111 days.

As held on the ledger · 2026-10-30
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 111 days
Price at the screen$77.57
Valuation12.63 trailing · 10.82 forward price to earnings
Values screenFAIL · score 30.0
Beta1.01
The Workings

Five Screens, Shown in Full

Does not pass. Excluded industry: Banks - Regional

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Excluded industry: Banks - Regional Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Webster Financial does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when WBS's ethical verdict changes

Today WBS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 30 Oct 2026: it trades at roughly a 4% discount to our $81.00 fair value, narrow competitive moat, 5.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

79.35Conservative81.00Base case132.24Growth case 77.57Price

Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 4.2% discount to the base estimate.

The Street's Range
72.00Street low 77.00Street average 81.00Street high 77.57Price

Third-party analyst targets: 11 covering, consensus Hold. The average target sits −1% from the screen price.

Reading the gap · Our model sees value the Street hasn't fully caught up to yet.

Price History & Projections

Where our models see it going: fair-value estimate $81.00, with a range of $79.35 to $132.24, dated to the 2026-10-30 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Regional banks fail before the numbers matter

Picture a family in New England walking into a branch for a mortgage or a local firm drawing down a line of credit. Webster Financial handles those everyday flows across three banking segments. Yet the business never clears the first gate.

The ethical screen rules it out outright because regional banks sit on the excluded list. Numbers such as 9 percent revenue growth, a 37 percent profit margin and a 10.4 times forward multiple do not change that verdict. Fair value sits only 7 percent above the current price and twelve analysts already call it a hold.

Banks are cyclical by nature, so a low multiple can simply mark peak earnings rather than a bargain. Currency and rate swings add further pressure that a narrow moat cannot offset. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E10.8xpriced for continued growth
Trailing P/E12.6xreasonably valued
EPS, trailing6.14
EPS, forward7.05
Revenue growth+5.8%slow but positive growth
Profit margin36.8%highly profitable on every dollar of sales
Return on equity10.7%a modest return on shareholder capital
Dividend yield2.12%
Beta1.01moves a little more than the market
52-week range52.69 - 79.74
MoatNARROW
Market cap$12.6B
Employees4,498

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

WBS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-03 Accumulation $77.57 +0.0% Entry 15

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74.

2026-10-22 Accumulation $77.57 +0.0% Entry 14

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Accumulation $77.57 +0.0% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-20 Accumulation $77.57 +0.0% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-19 Accumulation $77.57 +0.0% Entry 11

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Accumulation $77.57 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-17 Accumulation $77.57 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-16 Accumulation $77.57 +0.0% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-15 Accumulation $77.57 +0.0% Entry 7

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-02 Accumulation $77.57 +0.0% Entry 6

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (12 analysts) rates it none, with a mean price target of $74.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on WBS

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in WBS's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $72.15 -0.4% $0.40 $1,001 +0.1%
2 months $71.39 +0.6% $0.40 $1,012 +1.2%
3 months $67.53 +6.4% $0.40 $1,070 +7.0%
6 months $63.23 +13.6% $0.80 $1,149 +14.9%
1 year $53.55 +34.2% $1.60 $1,371 +37.1%
2 years $38.71 +85.6% $3.20 $1,938 +93.8%
3 years $35.33 +103.3% $4.80 $2,169 +116.9%
5 years $48.71 +47.5% $8.00 $1,639 +63.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever WBS does next, these words stay.

Webster Financial Corp · WBS · Accumulation · $77.57
Recorded 2026-10-30 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.